Regorafenib Tablets Impurity – C
4-[3-fluoro-4-[[2-(methylcarbamoyl)pyridin-4-yl]amino]phenoxy]-N-methylpyridine-2-carboxamide
| Chemical Name | 4-[3-fluoro-4-[[2-(methylcarbamoyl)pyridin-4-yl]amino]phenoxy]-N-methylpyridine-2-carboxamide |
|---|---|
| CAS No. | 1855006-12-0 |
| Molecular Formula | C20H18FN5O3 |
| Molecular Weight | 395.39 |
| Chemical Structure |
|
| Get a Quote | |
Regorafenib Tablets Impurity – C
Regorafenib Tablets Impurity – C is identified as a process-related impurity of Regorafenib Tablets in accordance with EP specifications. Chemically, it is described as 4-[3-fluoro-4-[[2-(methylcarbamoyl)pyridin-4-yl]amino]phenoxy]-N-methylpyridine-2-carboxamide. It has the molecular formula C20H18FN5O3 and a molecular weight of 395.39 g/mol. Laboratories use this reference standard for impurity identification, method validation, and batch release testing related to Regorafenib Tablets. Available as a high-purity certified reference material suitable for HPLC, LC-MS, and other analytical techniques.
Regorafenib Tablets impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, Quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.
We are the BHAVANISH LIFE SCIENCES specializes in manufacturing and supplying of Regorafenib Tablets impurities that meet specific pharmacopeial standards (USP/EP/BP/IP) as well as process-related impurities.
This related products or Impurities are thoroughly characterized. Supplied with detailed COA & analytical data Like NMR / MASS / HPLC / GC / IR / TGA / Potency / Structure elucidation data (SER Report) meeting regulatory compliance.
BHAVANISH LIFE SCIENCES provides this compound for research and development and Analytical testing use only, and is not meant for human consumption. With product information including CAS number, molecular formula, molecular weight details.
BHAVANISH LIFE SCIENCES in providing high-quality impurity standards to support pharmaceutical companies in maintaining drug safety and efficacy.
Related Search Terms & Supply Information
buy high quality Regorafenib Tablets Impurity – C
Purchase Regorafenib Tablets Impurity – C
Regorafenib Tablets Impurity – C suppliers
Regorafenib Tablets Impurity – C manufacturers
Regorafenib Tablets Impurity – C price
Order Regorafenib Tablets Impurity – C
Enquire Regorafenib Tablets Impurity – C
Regorafenib Tablets Impurity – C cost
Regorafenib Tablets Impurity – C Supplier
Regorafenib Tablets Impurity – C Distributor
Regorafenib Tablets Impurity – C for Method Validation
Regorafenib Tablets Reference Standard
Regorafenib Tablets Impurity – C for ANDA Filing
Regorafenib Tablets Impurity – C for Forced Degradation Studies
Regorafenib Tablets Impurity – C Identification Standards
Regorafenib Tablets Impurity – C for DMF Filing
Regorafenib Tablets Impurity – C analytical standards
Regorafenib Tablets Impurity – C impurity standard
Regorafenib Tablets Impurity – C pharmacopeial standards
Regorafenib Tablets Impurity – C for QC testing